Amyotrophic lateral sclerosis Treatment in Beike Biotechnology
About the clinic
Amyotrophic lateral sclerosis (ALS) treatment at Shenzhen Beike Biotechnology in Shenzhen, China, focuses on slowing disease progression through regenerative cell therapy. The clinic is known for its high safety standards, holding multiple accreditations including ISO 9001, AABB, and CAP. This facility uses a rigorous process with over 900 quality checkpoints for every cell dose to help patients manage motor neuron disease symptoms.
Stem cell therapy for ALS
The clinic uses umbilical cord-derived stem cells to treat ALS and primary lateral sclerosis (PLS). This method targets inflammation in the central nervous system, which is a major driver of the disease. By reducing this inflammation, the therapy aims to protect remaining nerves and promote repair. Data from 59 patients treated at the facility shows that 64% reported an improvement in their quality of life, while 47% saw better results regarding spasticity.
Patients receive stem cells through two different delivery routes. Intravenous injections deliver cells into the bloodstream, while intrathecal injections place them directly into the spinal fluid. This dual approach helps the cells reach the affected areas more effectively.
Treatment protocols and rehabilitation
The therapy is delivered over several days and involves a high concentration of cells to maximize the potential for nerve repair. The clinic offers two main protocols based on the patient's needs:
- Standard protocol. This involves 3–8 injections over a stay of 10–23 days. It typically includes 120–280 million stem cells.
- High-dose protocol. This intensive option requires a minimum stay of 8 days and provides up to 200 million cells per cycle.
Treatment includes a daily rehabilitation program to support the effects of the cell injections. Patients participate in physiotherapy, aquatherapy, and occupational therapy. The protocol also features Transcranial Magnetic Stimulation (TMS), hyperbaric oxygen therapy, and acupuncture. A specialized nutrition program is included to support overall physical health during the stay.
Safety and experience
The clinic has treated 33,000+ patients since 2005 and has contributed to 50+ peer-reviewed papers in medical journals. Each cell package comes with a unique traceability code to verify its origin and quality. The stem cells are ethically sourced from umbilical cords and processed in labs accredited by CNAS and GMP standards. For more information about the treatment process, you may leave a request on Bookimed.
Highlights
Get a free consultation
The clinic is not accepting new requests
Average answering time – 5 minutes
Accepted payment methods
View more information
Treatments prices in the clinic
| treatment | Price | |
|---|---|---|
| Gross Therapy | Price on request | |
| Occupational therapy | Price on request | |
| Multiple sclerosis rehabilitation | Price on request | |
| Transcranial magnetic stimulation (TMS) | Price on request |
How are we doing?
hospital accreditation of quality
Beike Biotechnology: more details about the clinic
Founded in 2005, **Shenzhen Beike Biotechnology** is a specialized research organization in Shenzhen, China. The center focuses on adult stem cell research and clinical translation. It manages the entire therapeutic process—from donor selection and cell processing to delivery for clinical use.
National and International Recognitions
The company holds several international quality management certifications:
- ISO 9001 and ISO 17025 certificates
- ISO 45001 and ISO 14001 certificates
- Accreditation from the College of American Pathologists (CAP)
- FDA Drug Master File recognition
Its cell bank meets GMP and AABB standards. In 2011, the Jiangsu Beike inspection center received CNAS accreditation. This made it the first adult stem cell processing laboratory in China to earn this status. Beike is also a member of the **International Society for Cell Therapy (ISCT)**.
Patient Statistics and Research Achievements
The center has treated over 33,500 patients from more than 60 countries. As a research-driven institution, it has published nearly 50 peer-reviewed papers in journals like **Nature**. The company participates in over 60 government projects, including six at the state level. This research directly shapes their stem cell processing and treatment protocols.
Specialized Stem Cell Programs
Beike develops specialized protocols for neurological, neuromuscular, and degenerative conditions. Each treatment cycle combines stem cell transplantation with supportive therapies. The medical team includes specialists such as Dr. Ice, who oversees individualized treatment planning.
Cerebral Palsy Care
The center treats cerebral palsy using a structured two-week protocol. This program pairs stem cell therapy with intensive daily rehabilitation. According to follow-up data from 253 patients:
- 88% reported physical improvement
- 90% reported improved quality of life
- 87% expressed satisfaction with the treatment outcome
Neuromuscular Disorders
The clinic provides specialized care for Duchenne and Becker muscular dystrophy. Specialists use **mesenchymal stem cells (MSCs)** through various administration routes. Registry data shows 85% of these patients reported quality of life improvements. For Spinal Muscular Atrophy, 94% reported improved limb muscle strength.
Integrated Rehabilitation
Every stem cell treatment cycle includes daily multi-modal rehabilitation. These sessions create the right environment for transplanted cells to function. The center offers several supportive therapies:
- Physiotherapy and aquatherapy
- Hyperbaric oxygen therapy
- Transcranial magnetic stimulation (TMS)
- Occupational therapy and acupuncture
Acupuncture helps transmit signals to the brain and spinal cord. This supports pain management and improves nervous system response during recovery.
Verification and Safety Protocols
The center uses a proprietary traceability system for every cell package. This system includes over **900 quality checkpoints**. Lab technicians perform quality checks twice, with one round from an independent laboratory. If a dose fails any checkpoint, it is not released for clinical use.
Every product label features a unique traceability code. Patients and doctors can enter this code into an online verification system. They can then view batch information, quality testing results, and release status in real time. This transparent workflow confirms the safety and origin of every dose.
Services for International Patients
Beike offers coordinated support for patients traveling from outside China. Representatives guide international visitors through each stage of the medical assessment. The center arranges private transportation and provides private room accommodations. Meals are delivered directly to the patient's room during their stay.
Care continues after patients return home through a one-year follow-up program. The medical team sends regular forms via email to track progress. Patients also receive a customized home program to continue supporting the transplanted stem cells.
Additional services
Requirements for admission
Bangkok, Thailand
Get a free consultation
The clinic is not accepting new requests
Average answering time – 5 minutes
How it works:
- We find a medical coordinator familiar with the matter
- You get a personal offer with a step-by-step guide and the cost estimate
- We arrange your travel including appointment scheduling and flights booking
- You arrive at the hospital, we support you 24/7